Segall Bryant & Hamill’s Guardant Health GH Stock Holding History

Segall Bryant & Hamill’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.5M	Buy	236,340 +4,118	+2%	+$448K	0.42%	53
2026 Q1	$21.5M	Sell	232,222 -12,044	-5%	-$1.21M	0.31%	107
2025 Q4	$24.9M	Sell	244,266 -60,881	-20%	-$5.45M	0.34%	99
2025 Q3	$19.1M	Buy	305,147 +111,822	+58%	+$6.08M	0.25%	140
2025 Q2	$10.1M	Buy	+193,325	New	+$8.63M	0.14%	230

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Segall Bryant & Hamill's GH Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Guardant Health (GH) stake by 1.8% in Q2 2026, buying an estimated $448K and bringing the position to 236,340 shares worth $35.5M. The position accounts for 0.42% of the portfolio, ranked #53.

Segall Bryant & Hamill first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Segall Bryant & Hamill held 236,340 shares of Guardant Health worth $35.5M as of Q2 2026.
Segall Bryant & Hamill bought 4,118 Guardant Health shares in Q2 2026, an estimated $448K.
Guardant Health made up 0.42% of Segall Bryant & Hamill's portfolio in Q2 2026, its #53 holding.
Segall Bryant & Hamill first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.